Location History:
- Spring House, PA (US) (2015)
- Malvern, PA (US) (2007 - 2019)
- Pacifica, CA (US) (2020 - 2021)
- San Francisco, CA (US) (2021 - 2024)
Company Filing History:
Years Active: 2007-2024
Title: Jacqueline Benson: A Pioneer in Anti-IL-23 Therapeutics
Introduction
Jacqueline Benson, a distinguished inventor based in Malvern, PA, has made significant strides in the field of medical devices and therapeutics. With an impressive portfolio of 22 patents, Benson is recognized for her innovative contributions to the development of anti-IL-23 antibodies, which have critical applications in treating various medical conditions.
Latest Patents
Benson's latest patents focus on groundbreaking medical devices for administering anti-IL-23 antibodies. One of her key inventions includes a human anti-IL-23p19 antibody, which comes with isolated nucleic acids that encode at least one anti-IL-23p19 antibody. This invention encompasses vectors, host cells, and developed methods for making and utilizing these antibodies in diagnostic and therapeutic compositions. Another important patent details an anti-IL-23 antibody, which also includes isolated nucleic acids and vectors, as well as transgenic animals or plants, providing robust methods to use these compositions in medical applications.
Career Highlights
Throughout her career, Jacqueline Benson has worked with esteemed organizations such as Janssen Biotech, Inc. and Centocor, Inc., where she has applied her expertise in developing innovative medical solutions. Her work focuses on enhancing the efficacy of treatments through advanced antibody technology and therapeutic devices.
Collaborations
Benson's collaborations with other notable professionals, including Mark Hilary Cunningham and Raymond W. Sweet, have contributed to her success in advancing therapeutic applications of her inventions. These partnerships have allowed her to leverage diverse insights and expertise in the field of biomedical innovation.
Conclusion
Jacqueline Benson stands out as a leading inventor in the realm of anti-IL-23 therapeutics, with her cutting-edge inventions poised to make a lasting impact on medical treatments. Her dedication, innovative spirit, and collaboration with industry experts highlight her role as a vital force in the advancement of medical technology.